Predictive research to strengthen market leadership

Novartis had secured early market access with a breakthrough oncology therapy, enjoying a period of exclusivity. But as competitors gained momentum—advancing R&D, launching rival treatments and asserting thought leadership —our client’s position faced mounting pressure. To defend its advantage and underscore the superiority of its therapy, supply chain and services, the company turned to us to build a defensible market moat through precision stakeholder engagement.

Our research delved deep into the radiopharmaceuticals landscape, identifying the dynamics shaping competitive positioning and emerging industry narratives. By leveraging proprietary NLP techniques and predictive AI tools, we uncovered white space opportunities, anticipated shifts in the market trajectory and mapped out communication pathways to reinforce our client’s leadership.